CN Patent

CN108503650B — 二噁烷并喹唑啉类化合物或其药用盐或其水合物及其作为酪氨酸激酶抑制剂的应用

Assigned to Beijing Scitech MQ Pharmaceuticals Ltd · Expires 2021-02-12 · 5y expired

What this patent protects

本发明涉及具有式(I)的二噁烷并喹唑啉类化合物或其可药用盐或其水合物。本发明还提供了一种式(I)所述化合物及其可药用盐的制备方法及其作为药物的应用，所述药物作为酪氨酸激酶(例如VEGFR‑2和c‑Met)抑制剂用于治疗与酪氨酸激酶相关的疾病。

USPTO Abstract

本发明涉及具有式(I)的二噁烷并喹唑啉类化合物或其可药用盐或其水合物。本发明还提供了一种式(I)所述化合物及其可药用盐的制备方法及其作为药物的应用，所述药物作为酪氨酸激酶(例如VEGFR‑2和c‑Met)抑制剂用于治疗与酪氨酸激酶相关的疾病。

Drugs covered by this patent

Patent Metadata

Patent number
CN108503650B
Jurisdiction
CN
Classification
—
Expires
2021-02-12
Drug substance claim
No
Drug product claim
No
Assignee
Beijing Scitech MQ Pharmaceuticals Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.